RACHEL YOUNG: Open Payments
NPI 1952031577 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$606 in 32 payments from 5 companies in 2025. Trend: 2023 $447 · 2024 $842 · 2025 $606
Food & beverage: $606
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $441 |
| Lundbeck LLC | 4 | $69 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| Astellas Pharma US Inc | 1 | $24 |
| Currax Pharmaceuticals LLC | 1 | $16 |
Products named: VRAYLAR, REXULTI, FARXIGA, Veozah, AIRSUPRA, CONTRAVE, EMRELIS.
Industry payments across OK — which companies pay providers there.
